Tumors with KRAS 12/13 mutations may exhibit a more aggressive tumor phenotype potentially due to the significant association of ADAM8 with the formation of distant metastases and the invasion of the tumor environment [41,42]. The gene discussed is KRAS; the disease is neoplasm.